BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21157852)

  • 1. The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.
    Simmons A; Westman E; Muehlboeck S; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Wahlund LO; Soininen H; Lovestone S; Evans A; Spenger C
    Int J Geriatr Psychiatry; 2011 Jan; 26(1):75-82. PubMed ID: 21157852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI measures of Alzheimer's disease and the AddNeuroMed study.
    Simmons A; Westman E; Muehlboeck S; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Wahlund LO; Soininen H; Lovestone S; Evans A; Spenger C;
    Ann N Y Acad Sci; 2009 Oct; 1180():47-55. PubMed ID: 19906260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
    Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
    Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.
    Lebedev AV; Westman E; Van Westen GJ; Kramberger MG; Lundervold A; Aarsland D; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Simmons A;
    Neuroimage Clin; 2014; 6():115-25. PubMed ID: 25379423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Liu Y; Paajanen T; Zhang Y; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    Neurobiol Aging; 2010 Aug; 31(8):1375-85. PubMed ID: 20447732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.
    Westman E; Aguilar C; Muehlboeck JS; Simmons A
    Brain Topogr; 2013 Jan; 26(1):9-23. PubMed ID: 22890700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.
    Nestor SM; Rupsingh R; Borrie M; Smith M; Accomazzi V; Wells JL; Fogarty J; Bartha R;
    Brain; 2008 Sep; 131(Pt 9):2443-54. PubMed ID: 18669512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.
    Cavedo E; Redolfi A; Angeloni F; Babiloni C; Lizio R; Chiapparini L; Bruzzone MG; Aquino D; Sabatini U; Alesiani M; Cherubini A; Salvatore E; Soricelli A; Vernieri F; Scrascia F; Sinforiani E; Chiarati P; Bastianello S; Montella P; Corbo D; Tedeschi G; Marino S; Baglieri A; De Salvo S; Carducci F; Quattrocchi CC; Cobelli M; Frisoni GB
    J Alzheimers Dis; 2014; 40(4):941-52. PubMed ID: 24577455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
    Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease.
    Wolz R; Julkunen V; Koikkalainen J; Niskanen E; Zhang DP; Rueckert D; Soininen H; Lötjönen J;
    PLoS One; 2011; 6(10):e25446. PubMed ID: 22022397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database.
    Cuingnet R; Gerardin E; Tessieras J; Auzias G; Lehéricy S; Habert MO; Chupin M; Benali H; Colliot O;
    Neuroimage; 2011 May; 56(2):766-81. PubMed ID: 20542124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer's disease.
    Im K; Lee JM; Seo SW; Hyung Kim S; Kim SI; Na DL
    Neuroimage; 2008 Oct; 43(1):103-13. PubMed ID: 18691657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
    Xu L; Wu X; Chen K; Yao L
    Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.
    Mangialasche F; Westman E; Kivipelto M; Muehlboeck JS; Cecchetti R; Baglioni M; Tarducci R; Gobbi G; Floridi P; Soininen H; Kłoszewska I; Tsolaki M; Vellas B; Spenger C; Lovestone S; Wahlund LO; Simmons A; Mecocci P;
    J Intern Med; 2013 Jun; 273(6):602-21. PubMed ID: 23343471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.